These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 25448242)
1. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research. Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242 [TBL] [Abstract][Full Text] [Related]
2. Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies. Lisboa SF; Vila-Verde C; Rosa J; Uliana DL; Stern CAJ; Bertoglio LJ; Resstel LB; Guimaraes FS Psychopharmacology (Berl); 2019 Jan; 236(1):201-226. PubMed ID: 30604182 [TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system in the amygdala and modulation of fear. Gunduz-Cinar O Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110116. PubMed ID: 32976951 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder. Ney LJ; Matthews A; Bruno R; Felmingham KL Neurosci Biobehav Rev; 2018 Nov; 94():302-320. PubMed ID: 30017748 [TBL] [Abstract][Full Text] [Related]
5. Targeting the endocannabinoid system to treat anxiety-related disorders. Korem N; Zer-Aviv TM; Ganon-Elazar E; Abush H; Akirav I J Basic Clin Physiol Pharmacol; 2016 May; 27(3):193-202. PubMed ID: 26426887 [TBL] [Abstract][Full Text] [Related]
6. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. Hill MN; Campolongo P; Yehuda R; Patel S Neuropsychopharmacology; 2018 Jan; 43(1):80-102. PubMed ID: 28745306 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. Mizrachi Zer-Aviv T; Segev A; Akirav I Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological intervention of conditioned fear and its extinction]. Huang R; Li Z; Chen H; Huang Y; Ding L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):968-72. PubMed ID: 23000774 [TBL] [Abstract][Full Text] [Related]
9. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction. Laricchiuta D; Centonze D; Petrosini L Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212 [TBL] [Abstract][Full Text] [Related]
10. Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders. Korem N; Lange R; Hillard CJ; Akirav I Neuroscience; 2017 Aug; 357():285-294. PubMed ID: 28624572 [TBL] [Abstract][Full Text] [Related]
11. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD. Surís A; Holliday R; Adinoff B; Holder N; North CS Psychiatry; 2017; 80(4):399-410. PubMed ID: 29466111 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice. Mayo LM; Asratian A; Lindé J; Holm L; Nätt D; Augier G; Stensson N; Vecchiarelli HA; Balsevich G; Aukema RJ; Ghafouri B; Spagnolo PA; Lee FS; Hill MN; Heilig M Mol Psychiatry; 2020 May; 25(5):993-1005. PubMed ID: 30120421 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid modulation of corticolimbic activation during extinction learning and fear renewal in adults with posttraumatic stress disorder. Zabik NL; Rabinak CA; Peters CA; Iadipaolo A Neurobiol Learn Mem; 2023 May; 201():107758. PubMed ID: 37088409 [TBL] [Abstract][Full Text] [Related]
14. Regulation of fear extinction by long-term depression: The roles of endocannabinoids and brain derived neurotrophic factor. Bennett MR; Arnold J; Hatton SN; Lagopoulos J Behav Brain Res; 2017 Feb; 319():148-164. PubMed ID: 27867101 [TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. Berardi A; Schelling G; Campolongo P Pharmacol Res; 2016 Sep; 111():668-678. PubMed ID: 27456243 [TBL] [Abstract][Full Text] [Related]
16. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077 [TBL] [Abstract][Full Text] [Related]
17. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers. de Bitencourt RM; Pamplona FA; Takahashi RN Neuropharmacology; 2013 Jan; 64():389-95. PubMed ID: 22687521 [TBL] [Abstract][Full Text] [Related]
18. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833 [TBL] [Abstract][Full Text] [Related]
19. Differential roles of the infralimbic and prelimbic areas of the prefrontal cortex in reconsolidation of a traumatic memory. Levin N; Kritman M; Maroun M; Akirav I Eur Neuropsychopharmacol; 2017 Sep; 27(9):900-912. PubMed ID: 28647452 [TBL] [Abstract][Full Text] [Related]
20. The role of endocannabinoids in consolidation, retrieval, reconsolidation, and extinction of fear memory. Mizuno I; Matsuda S Pharmacol Rep; 2021 Aug; 73(4):984-1003. PubMed ID: 33954935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]